Skip to content
Products
Solutions
Pricing
Resources
Company
Sign in
Request a demo
Blog Overview
See all of our blog posts in all categories by date.
Blog: All
How this psychedelic drug company went private and raised a $103M Series A
The CEO of Reunion Neuroscience, a company developing a drug to treat postpartum depression and mental health distress related to cancer, took a unique approach to advance company goals.
Carta Policy Insights: Decoding the Data | Startup job creation
From traditional startup hubs to emerging entrepreneurial ecosystems across the country, these ventures are fueling employment opportunities, reshaping the American economy, and leading to our competitive edge.
Streamlining equity issuance with Carta’s Draft Option API
This integration allows shared customers with our partners to draft option grants and generate legal documents for issuing equity directly from the Carta dashboard.
Carta announces exclusive streamlined solution with Morgan Stanley at Work for private companies seeking to IPO
Morgan Stanley at Work to become Carta’s preferred U.S. public equity management platform, aligning world-class cap table management and IPO readiness with public equity compensation solutions and wealth management.
Carta’s Compliance & Tax Hub: Proactive, real-time guidance to help you stay on top of regulatory requirements
Now, you can view your company's status for 409A valuation, QSBS eligibility, Form 3921, and more—all from a single, actionable dashboard. Think of it as your command center for compliance.
Trump returning to White House with GOP Congress
Republican control in the House and Senate will allow the president-elect to more easily implement his agenda on a variety of issues.
Previous
85
86
87
88
89
90
91
92
93
Next
Want to see how Carta works?
Request a demo